Will The Pfizer-Mylan Deal Face Antitrust Hurdles?

 
• By Brenda Sandburg
  
WASHINGTON, DC - MAY 4: Federal Trade Commission Headquarters in downtown Washington, DC on May 4, 2015.
Pfizer-Mylan proposed transaction faces FTC scrutiny

More from Legal & IP

More from Pink Sheet